1Rehabilitation Department, Carol Davila University of Medicine and Pharmacy, Romania
2Doctoral School, Carol Davila University of Medicine and Pharmacy, Romania
*Corresponding author:Miruna Ioana Sandulescu, Doctoral School, Carol Davila University of Medicine and Pharmacy, 4192910 Bucharest, Romania
Submission: June 10, 2023; Published: August 04, 2023
ISSN: 2637-7934Volume 4 Issue 2
Introduction: Achieving successful control of spasticity can represent a significant therapeutic challenge.
The numerous complications need to be anticipated and properly managed through a complex and
personalized therapeutic approach.
Objectives: Depending on the degree of spasticity, its duration, and the motor control in the targeted
segment, the therapeutic objectives can vary considerably concerning spasticity in the context of stroke
(AVC).
Materials and Methods: Four case studies are presented, involving patients with stroke and spasticity
ranging from grade 1+ to 4 (measured using the Modified Ashworth Scale-MAS), with varying duration
and motor control in the affected segments. These patients underwent a conservative rehabilitation
treatment and received botulinum toxin administration. Evaluating spasticity is crucial to determine
treatment effectiveness and plan medical applications. It also helps measure and, ultimately, decide the
goals of rehabilitation treatment. Therefore, different functional clinical scales are used based on the
characteristics of spasticity in each case, allowing for a better dynamic evaluation and quantification
of motor impairment, leading to more accurate setting and monitoring of therapeutic objectives and
methods.
Result and Discussion: Consistent application of botulinum toxin treatment for high-intensity spasticity
led to long-term improvement in pain syndrome in the affected limb and prevented further damage to
periarticular tissues. For cases of low-intensity spasticity in a limb with mild motor deficits, restoring
functionality to almost normal levels required the use of different functional scales, and botulinum toxin
administration was needed at intervals longer than three months, with progressively smaller doses.
Conclusion: Considering the variability in the functional status of patients with stroke and spasticity,
both functional evaluation and rehabilitation treatment objectives differ significantly. Therefore, the
injection of botulinum toxin calls for a personalized approach based on the patient, regarding dosage and
administration intervals.
Keywords:Botulinum toxin injection; Patients; Stroke; Therapeutic challenge; Treatment effectiveness; Self-Esteem